Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
/in International Publications, Micronutrients /von 2013-05-14 / Cancer Chemother. Pharmacol. 2013 Jul;72(1):139-46Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2013-05-01 / Anticancer Res. 2013 May;33(5):2047-56Identification of common gene networks responsive to mild hyperthermia in human cancer cells
/in Hyperthermia, International Publications /von 2013-04-30 / Int. J. Mol. Med. 2013 Jul;32(1):195-202Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2013-04-19 / Cancer Immunol. Immunother. 2013 Jun;62(6):1083-91Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLC /von 2013-04-16 / Cancer Immunol. Immunother. 2013 May;62(5):909-18Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy
/in Hyperthermia, International Publications /von 2013-04-14 / Evid Based Complement Alternat Med 2013;2013:672873Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2013-03-21 / Cancer Lett. 2013 Aug;336(2):253-9The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling
/in Hypernephroma, International Publications, Newcastle Disease Virus /von 2013-03-18 / J. Interferon Cytokine Res. 2013 Jul;33(7):346-54A low selenium level is associated with lung and laryngeal cancers
/in International Publications, Micronutrients /von 2013-03-13 / PLoS One 2013;8(3):e59051
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de